Related references
Note: Only part of the references are listed.C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3
Toni Schwarz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer
April A. N. Rose et al.
CLINICAL CANCER RESEARCH (2010)
Renal tumour suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin
V. Hudon et al.
JOURNAL OF MEDICAL GENETICS (2010)
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling
Seung-Beom Hong et al.
MOLECULAR CANCER (2010)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2010)
The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis
T. R. Hartman et al.
ONCOGENE (2009)
Gpnmb is a melanoblast-expressed, MITF-dependent gene
Stacie K. Loftus et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2
Yukiko Hasumi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dube gene pathway
Youfeng Yang et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB
Vera M. Ripoll et al.
GENE (2008)
Identification and characterization of a novel folliculin-interacting protein FNIP2
Hisashi Hasumi et al.
GENE (2008)
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys
Masaya Baba et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate
Xiaozhong Qian et al.
MOLECULAR ONCOLOGY (2008)
Novel MITF targets identified using a two-step DNA microarray strategy
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
Jindong Chen et al.
PLOS ONE (2008)
Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas
M. Mathur et al.
ONCOGENE (2007)
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors
Agnieszka Bronisz et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers
Ian J. Davis et al.
CANCER CELL (2006)
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme
CT Kuan et al.
CLINICAL CANCER RESEARCH (2006)
CR011, a fully human monoclonal anti body-auristatin E conjugate, for the treatment of melanoma
KF Tse et al.
CLINICAL CANCER RESEARCH (2006)
TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes
Y Nakagawa et al.
NATURE MEDICINE (2006)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome
LS Schmidt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Sumoylation of MITF and its related family members TFE3 and TFEB
AJ Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
K Okimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation
IJ Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog
F Lingaas et al.
HUMAN MOLECULAR GENETICS (2003)
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
ML Nickerson et al.
CANCER CELL (2002)
Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitfmi/mi mice
KN Weilbaecher et al.
MOLECULAR CELL (2001)
Share Paper
